Health Services Research
Latest posts by Health Services Research (see all)
- Income Dynamics and the Affordable Care Act - Oct. 20, 2014
- Payment Rates for Personal Care Assistants and the Use of Long-Term Services and Supports among… - Oct. 18, 2014
- Development of a Novel, Objective Measure of Health Care–Related Financial Burden for U.S…. - Oct. 18, 2014
- Population-Level Cost-Effectiveness of Implementing Evidence-Based Practices into Routine Care - Oct. 18, 2014
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: